Sangamo Therapeutics, Inc. (SGMO) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
06M12M19M25M31M38M44M50MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
09M18M26M35M44M52M61M70MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-50M-44M-37M-31M-25M-19M-12M-6M1Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EPS

Revenue Variation (%)

Revenue Variation
-2002006001K1K2K2K3K3KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Variation (%)

Gross Profit VariationOperating Income Variation
03875112150188225262300Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-2005751K2K3K4K4K5K6KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
07502K2K3K4K4K5K6KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-3-2-2-2-1-0001Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0625K1M2M2M3M4M4M5MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
0918263544526170Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
06M12M19M25M31M38M44M50MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
05M10M15M20M25M30M35M40MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics